Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Waters unveils next-generation mass spectrometry platform

Waters : 22 January, 2008  (New Product)
Waters has launched the Waters Synapt MS system, a next-generation quadrupole acceleration, time-of-flight mass spectrometry platform and is the only platform to provide an upgrade pathway to the Synapt High Definition MS (HDMS) system.
Synapt MS is a key part of Waters' strategy to enhance the quality and productivity of life science and drug discovery and development workflows.

The Synapt MS system enables researchers to analyse samples differentiated by size, shape and charge, as well as mass, ultimately providing new capabilities that can help them meet and exceed future requirements.

“Confident sample identification, detailed characterisation and increased productivity are primary requirements for intelligent mass spectrometry-based solutions in key biomedical applications such as proteomics, metabonomic profiling, Biomarker discovery/validation and pharmaceutical R&D,” said Brian W Smith, vice president, Mass Spectrometry Operations for the Waters Division. “The new Synapt MS meets these demands through application specific system solutions designed to help our customers accelerate and improve the quality of laboratory analysis with the goal of advancing research and reducing time-to-market.”

Synapt MS is a central component of Waters' system level solutions - combining Acquity UltraPerformance LC (UPLC) separations, Exact Mass MSE data acquisition and ‘chemically intelligent’ MassLynx Informatics - designed to generate high quality, comprehensive data from complex biological samples, maximise confidence in results and enable scientists to make better informed decisions.

Synapt MS Systems also offer unparalleled versatility and flexibility. For example, the MALDI-enabled Synapt MS system enables researchers to perform MALDI imaging studies, primarily to determine the spatial localisation of drugs, metabolites and peptides in biological tissues with high specificity and sensitivity. This can enable greater numbers of candidates to be evaluated in the drug discovery phase, leading to more rigorous selection of compounds for ongoing development.

”A unique aspect of the Synapt MS System is that it is ‘HDMS-ready.’ Our customers will be able to upgrade their systems to incorporate the unique High Definition MS capabilities when they require more powerful solutions to meet their future goals, effectively future-proofing their laboratories,” added Smith.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo